Nicastro, Nicolas http://orcid.org/0000-0002-5836-0792
Holland, Negin
Savulich, George
Carter, Stephen F.
Mak, Elijah
Hong, Young T.
Milicevic Sephton, Selena
Fryer, Tim D.
Aigbirhio, Franklin I.
Rowe, James B.
O’Brien, John T.
Funding for this research was provided by:
Wellcome Trust (103838)
NIHR Cambridge MRC CBU
Cambridge Center for Parkinson Plus
Patrick Berthoud Charitable Trust
Article History
Received: 1 July 2020
Accepted: 15 November 2020
First Online: 22 December 2020
Ethics approval and consent to participate
: The East of England institutional review boards approved the NIMROD (13/EE/0104), TENDER (16/EE/0529) and SENDER (18/EE/0059) protocols and written informed consent was obtained from all participants prior to inclusion.
: All subjects included in the present study have signed a consent form for publication.
: N. N., N.H., G.S., S.F.C., E.M., Y.T.H., S.M.S. and T.D.F. declare that they have no conflict of interests. F.I.A. received academic grant support from GE Healthcare and served as a consultant for Avid and Cantabio, all for matters not related to the current study. J.B.R. has been a consultant for Asceneuron and Syncona and has received academic grant funding from AZ-MedImmune, Janssen and Lilly, unrelated to this study. J.T.O. reports personal fees from TauRx, personal fees from Axon, personal fees from GE Healthcare, grants and personal fees from Avid/Lilly, personal fees from Eisai, grants from Alliance Medical, personal fees from Roche and grants from Merck, outside the submitted work.